HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
MNKD
MannKind Corporation
MNKD lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
MNKD Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Weak | |
| Weak |
MNKD's revenue is currently strong, but its profitability, cash flow and balance sheet are weak.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
MNKD PE Valuation
MNKD has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 178x next year's earnings.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
MNKD Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
MNKD has the edge over HIMS on the outlook, with more favorable earnings and profitability expectations.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
MNKD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.02 | — |
| Q3 2026 | -$0.23 | -330% |
| Q2 2026 | -$0.13 | -218% |
| Q1 2026 | -$0.07 | -170% |
| Q4 2025 | $0.02 | -80% |
| Q3 2025 | $0.10 | +25% |
| Q2 2025 | $0.11 | +120% |
| Q1 2025 | $0.10 | +150% |
| Q4 2024 | $0.10 | +$0.14 |
MNKD has swung to a loss: it lost $0.23 per share over the past year, after a profit the year before.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over MNKD on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
MNKD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $101.9M | +24% |
| Q2 2026 | $109.4M | +43% |
| Q1 2026 | $90.2M | +15% |
| Q4 2025 | $112M | +46% |
| Q3 2025 | $82.1M | +17% |
| Q2 2025 | $76.5M | +5.7% |
| Q1 2025 | $78.4M | +18% |
| Q4 2024 | $76.8M | +31% |
MNKD's revenue has grown year over year for 17 quarters in a row: $102M last quarter, up 24% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -2.1% | -25 points |
| Q2 2026 | -0.3% | -7.2 points |
| Q1 2026 | -1.9% | -30 points |
| Q4 2025 | -6.9% | -41 points |
| Q3 2025 | 23% | +4.8 points |
| Q2 2025 | 6.9% | -16 points |
| Q1 2025 | 28% | +3.2 points |
| Q4 2024 | 35% | +21 points |
MNKD has the edge over HIMS on profitability, with a higher operating margin.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over MNKD on cash generation, producing positive trailing cash flow while its opponent burns cash.
MNKD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$37.8M | -268% |
| Q2 2026 | -$23.5M | -399% |
| Q1 2026 | -$7.2M | -$538K |
| Q4 2025 | -$10M | -150% |
| Q3 2025 | $22.5M | +184% |
| Q2 2025 | $7.8M | +810% |
| Q1 2025 | -$6.7M | -256% |
| Q4 2024 | $19.7M | +25% |
MNKD has burned cash in most quarters: −$78M over the past year, against $43M the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over MNKD on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
MNKD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +11M shares |
| 1 year | +2.7% | +8.5M shares |
| 3 years | -1.1% | -3.6M shares |
| 5 years | +28% | +70.3M shares |
| Available history | +55% | +113M shares |
MNKD has 320M diluted shares, up 2.7% from a year ago.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
MNKD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 19.7x | High |
| Q2 2026 | 8.9x | High |
| Q1 2026 | 8.5x | High |
| Q4 2025 | 5.5x | High |
| Q3 2025 | -0.2x | Net Cash |
| Q2 2025 | -0.3x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.1x | Net Cash |
MNKD's net debt is about 20 years of its operating earnings (EBITDA), after holding more cash than debt a year ago.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
MNKD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.4 | Neutral |
| Stochastic | 63.7 | Neutral |
MNKD's weekly RSI is 55 (neutral) and its Stochastic is 64 (neutral).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
MNKD PE vs Healthcare Sector
| Metric | MNKD | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
MNKD has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
MNKD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 18% above |
| 20 week MA | $3.82 | 8.9% above |
| 50 week MA | $4.00 | 4% above |
| 100 week MA | $4.48 | 7.1% below |
| 200 week MA | $4.62 | 10% below |
MNKD has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
MNKD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.37 | $3.42 | +150% |
| 2021 | $3.42 | $4.46 | +30% |
| 2022 | $4.46 | $5.09 | +14% |
| 2023 | $5.09 | $3.64 | -28% |
| 2024 | $3.64 | $6.82 | +87% |
| 2025 | $6.82 | $5.79 | -15% |
| 2026 YTD | $5.79 | $4.16 | -28% |
MNKD has the edge over HIMS on returns for 2026, with the stronger performance.